01.27.22
Presbyopia is inevitable for all patients, but with new products hitting the market and coming down the pipeline, it is becoming increasingly easier to manage. Blake Williamson, MD, MPH, and his cohost, Neda Nikpoor, MD, welcome Karl G. Stonecipher, MD, for an in-depth discussion about how they currently treat presbyopia and how they expect the management of this condition to evolve as new mechanisms of action are developed, FDA approved, and released.
View full description +
Subscribe
08.25.25
Ushering in the Future of Cataract and Refractive SurgeryRobert J. Weinstock, MD; Gary Wörtz, MD; and Blake K. Williamson, MD, MPH
07.22.25
Potential Implications and Benefits of Direct SLT TechnologyJ. Morgan Micheletti, MD; Blake K. Williamson, MD, MPH; and Gary Wörtz, MD
06.06.25
Breaking Down the enVista Voluntary RecallCathleen McCabe, MD; Brent Saunders; Gary Wörtz, MD; and Blake K. Williamson, MD, MPH
05.20.25
The Highs and Lows of Turning an Idea Into a BusinessJohn P. Berdahl, MD; Blake Williamson, MD, MPH; and Gary Wörtz, MD
04.22.25
Innovative Technologies to Revolutionize PracticeI. Paul Singh, MD; Gary Wörtz, MD; and Blake Williamson, MD, MPH
03.26.25
Managing the Learning Curve as an Early AdopterWilliam Wiley, MD; Blake Williamson, MD, MPH; and Gary Wörtz, MD
02.20.25
The Current State of Multifocal and Trifocal IOL TechnologiesBlake Williamson, MD, MPH; Gary Wörtz, MD; and William Plauché, MD
Show More